BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$62.48
+1.78%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$62.62
From 52W high−8.24%
Volume12.48M
Market cap$127.71B
P/E (TTM)13.8x
P/S (TTM)2.6x
Div yield4.03%
Key dataOct 30, 2026
Open
$62.62
From 52W high
−8.24%
Volume
12.48M
Market cap
$127.71B
ValuationView details →
P/E (Fwd)
9.7x
EV/EBITDA
4.8x
P/E (TTM)
13.8x
RSI (14)
55.6
MomentumView details →
1D Return
+1.78%
YTD Return
+16.35%
SummaryUpdated Sep 1, 2026
Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company founded in 1887 and headquartered in New York. The company was formed through the merger of Bristol-Myers Company and Squibb Corporation, with Bristol-Myers Company tracing its origins to the Clinton Pharmaceutical Company established by William McLaren Bristol and John Ripley Myers. Today, Bristol-Myers Squibb stands as one of the world's leading pharmaceutical companies, focusing on discovering, developing, and commercializing innovative medicines for serious diseases including cancer, cardiovascular conditions, immunological disorders, and neurological conditions.
Similar companies
Latest newsMore news →
BRISTOL MYERS SQUIBB CO said it will not advance PRX019 into clinical development.3d agoVEEVA SYSTEMS INC announced that executives from ASTRAZENECA PLC, BRISTOL MYERS SQUIBB CO, Grünenthal GmbH, NOVO NORDISK A S, Roche Holdings, Inc. and UCB SA are among those featured at Veeva Summit, which presents innovations in AI and data for an agent-based commercial model.3d ago